Efficacy of metoclopramide for the treatment of acute migraine

Medicine (Baltimore). 2019 Sep;98(37):e17065. doi: 10.1097/MD.0000000000017065.

Abstract

Background: In this study, we will assess the efficacy and safety of metoclopramide for the treatment of acute migraine (AM).

Methods: We will comprehensively search Cochrane Library, PUMBED, EMBASE, Google Scholar, Web of Science, Allied and Complementary Medicine Database, Chinese Biomedical Literature Database, and China National Knowledge Infrastructure from the inception to July 1, 2019 to identify any eligible studies. Only randomized controlled trials will be considered for inclusion. The study selection, data collection, and management will be completed by two authors independently. The risk of bias will be assessed using Cochrane risk of bias tool. RevMan 5.3 software will be used for statistical analysis.

Results: The primary outcome includes pain intensity, as measured by visual analogue scale or others. The secondary outcomes are success rate, requirement of rescue medicine, quality of life, relapse, and adverse events.

Conclusions: This study will summarize the latest evidence for the clinical efficacy and safety of metoclopramide for the treatment of AM.

Prospero registration number: PROSPERO CRD42019142795.

MeSH terms

  • Analgesics / adverse effects
  • Analgesics / therapeutic use*
  • Humans
  • Meta-Analysis as Topic
  • Metoclopramide / adverse effects
  • Metoclopramide / therapeutic use*
  • Migraine Disorders / drug therapy*
  • Randomized Controlled Trials as Topic
  • Systematic Reviews as Topic*

Substances

  • Analgesics
  • Metoclopramide